Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Diagnostic Microbiology and Infectious Disease|March 1, 1989
Pharmacokinetics and safety of lomefloxacin following multiple dosesT L Hunt, M A AdamsClinical Therapeutics|July 1, 1991
Comparison of the pharmacokinetic profiles of two oral controlled-release morphine formulations in healthy young adultsT L Hunt, R F KaikoThe Journal of Infectious Diseases|May 1, 1987
Oral antimicrobial therapy for adults with osteomyelitis or septic arthritisJ Black, T L Hunt, P J Godley, et al.Clinical Therapeutics|April 22, 1999
Pharmacokinetic interaction of sparfloxacin and digoxinR D Johnson, M B Dorr, T L Hunt, et al.Journal of Clinical Pharmacology|July 1, 1995
A double-blind, placebo-controlled, dose-ranging safety evaluation of single-dose intravenous dolasetron in healthy male volunteersT L Hunt, M Cramer, A Shah, et al.Clinical Therapeutics|August 10, 1999
Effects of food on the pharmacokinetics of sparfloxacinR D Johnson, M B Dorr, T L Hunt, et al.The Journal of Rheumatology|December 22, 1999
Celecoxib, a specific COX-2 inhibitor, has no significant effect on methotrexate pharmacokinetics in patients with rheumatoid arthritisA Karim, D S Tolbert, T L Hunt, et al.Clinical Pharmacology and Therapeutics|March 1, 1996
Safe coadministration of terbinafine and terfenadine: a placebo-controlled crossover study of pharmacokinetic and pharmacodynamic interactions in healthy volunteersB Robbins, C T Chang, J A Cramer, et al.Journal of Clinical Pharmacology|October 12, 1999
Pharmacokinetics, safety, and tolerability of single intravenous infusions of an adenosine agonist, AMP 579, in healthy male volunteersP N Zannikos, R I Baybutt, B X Boutouyrie, et al.The Annals of Pharmacotherapy|February 26, 1998
Effect of infusion rate on the pharmacokinetics and tolerance of intravenous dolasetron mesylateD C Dimmitt, T L Hunt, A J Spalitto, et al.Pageof 2